These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24389931)

  • 1. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging.
    Xu Y; Pan D; Zhu C; Xu Q; Wang L; Chen F; Yang R; Luo S; Yang M; Yan Y
    Mol Imaging Biol; 2014 Aug; 16(4):578-85. PubMed ID: 24389931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker.
    Zhu C; Xu Q; Pan D; Xu Y; Liu P; Yang R; Wang L; Sun X; Luo S; Yang M
    Contrast Media Mol Imaging; 2016; 11(2):99-105. PubMed ID: 26286841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Imaging of FSHR Expression in Tumors with
    Pan D; Liu G; Xu Y; Wang Y; Yue Y; Wang L; Yan J; Wang X; Yang R; Yang M
    Contrast Media Mol Imaging; 2017; 2017():2674502. PubMed ID: 29097913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of prostate tumors with 18F-Al-NOTA-MATBBN.
    Pan D; Yan Y; Yang R; Xu YP; Chen F; Wang L; Luo S; Yang M
    Contrast Media Mol Imaging; 2014; 9(5):342-8. PubMed ID: 24729577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.
    Varasteh Z; Aberg O; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Antoni G; Sandström M; Tolmachev V; Orlova A
    PLoS One; 2013; 8(12):e81932. PubMed ID: 24312607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.
    Dijkgraaf I; Franssen GM; McBride WJ; D'Souza CA; Laverman P; Smith CJ; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
    Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRPR-selective PET imaging of prostate cancer using [(18)F]-lanthionine-bombesin analogs.
    Carlucci G; Kuipers A; Ananias HJ; de Paula Faria D; Dierckx RA; Helfrich W; Rink R; Moll GN; de Jong IJ; Elsinga PH
    Peptides; 2015 May; 67():45-54. PubMed ID: 25797109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
    Hausner SH; Bauer N; Sutcliffe JL
    Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the performance of
    Pan D; Wang L; Wang X; Yan J; Xu Y; Yang M
    Int J Radiat Biol; 2022; 98(10):1571-1580. PubMed ID: 35389307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.
    Xu Q; Zhu C; Xu Y; Pan D; Liu P; Yang R; Wang L; Chen F; Sun X; Luo S; Yang M
    J Drug Target; 2015; 23(9):813-20. PubMed ID: 25758750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors.
    Su X; Cheng K; Jeon J; Shen B; Venturin GT; Hu X; Rao J; Chin FT; Wu H; Cheng Z
    Mol Pharm; 2014 Nov; 11(11):3947-56. PubMed ID: 24972326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated radiosynthesis and preclinical evaluation of Al[
    Huang S; Wu H; Li B; Fu L; Sun P; Wang M; Hu K
    Nucl Med Biol; 2020; 82-83():64-71. PubMed ID: 32088580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging.
    Hong H; Yan Y; Shi S; Graves SA; Krasteva LK; Nickles RJ; Yang M; Cai W
    Mol Pharm; 2015 Feb; 12(2):403-10. PubMed ID: 25581441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel facile method of labeling octreotide with (18)F-fluorine.
    Laverman P; McBride WJ; Sharkey RM; Eek A; Joosten L; Oyen WJ; Goldenberg DM; Boerman OC
    J Nucl Med; 2010 Mar; 51(3):454-61. PubMed ID: 20150268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Al
    Palangka CRAP; Hanaoka H; Yamaguchi A; Murakami T; Tsushima Y
    Ann Nucl Med; 2019 Oct; 33(10):733-739. PubMed ID: 31297699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Evaluation of [
    Huang J; Bai L; Shi D; Jiang W; Chen P; Dong Y; Zhang X; Peng J; Hou J; Lu Y; Huang X; Tang G; Huang S
    Mol Pharm; 2024 May; 21(5):2425-2434. PubMed ID: 38554143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
    Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
    Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.